The David H. Koch Institute for Integrative Cancer Research at MITThe David H. Koch Institute for Integrative Cancer Research at MIT

Massachusetts Institute of Technology

National Cancer Institute Cancer Center

Science + Engineering... Conquering Cancer Together

Convergence Scholars

Introducing the 2020-2021 KI Convergence Scholars. Marble Center Scholars (top row, left to right): Shengnan Huang (Belcher Lab), Alice Stanton (Langer Lab), Nicholas Lamson (Hammond Lab), Tahoura Samad (Bhatia Lab), Parisa Yousefpour (Irvine Lab), and Siddharth Krishnan (Anderson Lab).
MIT Center for Precision Cancer Medicine (bottom row, left to right): Daniel Goulet (Hemann Lab), Jeffrey Davis (Vander Heiden Lab), Jasmin Kruell (Koehler Lab), Ingred Goretti Rica (Yaffe Lab), Tigist Tamir (White Lab), and Ye Zhang (Manalis Lab).

The Convergence Scholars Program cultivates in postdoctoral trainees an integrative vision of science and technology. CSP will provide postdoctoral trainees opportunities to further their experiences and skills beyond the research laboratory. Scholars will learn more about the technology development life cycle by approaching it from various angles, including policy and regulations, technology transfer, education and outreach, business and finances, industry, and the clinic. At the core of this program are activities to further communication and management skills, as well as a focus on translational impact. Participant activities and benefits include workshops in science management and science leadership, deeper engagement with industry, and professional development activities. Supplementing the primary benefit of leadership training and an enhanced perspective in science communication and management, postdoctoral trainees participating in the program will receive a limited stipend to support professional development activities.